Vertex Pharmaceuticals Inc at Cowen Health Care Conference Transcript
[TD Cowen's 43rd] Annual Health Care Conference. I'm Phil Nadeau, one of Cowen's biotech analysts and it's my pleasure to do a fireside chat one of the bellwethers of the industry, Vertex. Happy to have with us today, president and CEO, Reshma Kewalramani; and Charlie Wagner, CFO.
Reshma, I'll hand it to you first for some opening remarks.
Sure. Phil, thank you so much for having us here. it's wonderful to see all of you in person in our home city of Boston.
To start with, maybe I'll just give you a little bit of a flavor for where Vertex is today, touch on a few of our programs and then Phil, we can go into any one of those that you'd like to. It is an extraordinarily exciting time for us at Vertex. Having now brought 4 CF medicines to market and transformed that disease. The growth in our CF franchise has transformed Vertex. We are now involved in 8 disease areas, including
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
